|
PB 20 of 2023
Determinations/Health as made
|
|
This instrument amends the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 by adding various forms, not brands of warfarin that are currently subject to a Therapeutic Goods Administration (TGA) Serious Scarcity Substitution Instrument (SSSI). This allows supplies made under the TGA SSSI to be PBS subsidised.
|
|
Administered by: Health and Aged Care
|
Sunset Details
Sunset Date
|